{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T05:55:14Z","timestamp":1774936514721,"version":"3.50.1"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Syst Biol"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Alzheimer\u2019s disease (AD) is the most common cause of dementia among the elderly. To clarify pathogenesis of AD, thousands of reports have been accumulating. However, knowledge of signaling pathways in the field of AD has not been compiled as a database before.<\/jats:p><\/jats:sec><jats:sec><jats:title>Description<\/jats:title><jats:p>Here, we have constructed a publicly available pathway map called \u201cAlzPathway\u201d that comprehensively catalogs signaling pathways in the field of AD. We have collected and manually curated over 100 review articles related to AD, and have built an AD pathway map using CellDesigner. AlzPathway is currently composed of 1347 molecules and 1070 reactions in neuron, brain blood barrier, presynaptic, postsynaptic, astrocyte, and microglial cells and their cellular localizations. AlzPathway is available as both the SBML (Systems Biology Markup Language) map for CellDesigner and the high resolution image map. AlzPathway is also available as a web service (online map) based on Payao system, a community-based, collaborative web service platform for pathway model curation, enabling continuous updates by AD researchers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>AlzPathway is the first comprehensive map of intra, inter and extra cellular AD signaling pathways which can enable mechanistic deciphering of AD pathogenesis. The AlzPathway map is accessible at<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/alzpathway.org\/\" ext-link-type=\"uri\">http:\/\/alzpathway.org\/<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1752-0509-6-52","type":"journal-article","created":{"date-parts":[[2012,8,3]],"date-time":"2012-08-03T08:14:02Z","timestamp":1343981642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":123,"title":["AlzPathway: a comprehensive map of signaling pathways of Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"6","author":[{"given":"Satoshi","family":"Mizuno","sequence":"first","affiliation":[]},{"given":"Risa","family":"Iijima","sequence":"additional","affiliation":[]},{"given":"Soichi","family":"Ogishima","sequence":"additional","affiliation":[]},{"given":"Masataka","family":"Kikuchi","sequence":"additional","affiliation":[]},{"given":"Yukiko","family":"Matsuoka","sequence":"additional","affiliation":[]},{"given":"Samik","family":"Ghosh","sequence":"additional","affiliation":[]},{"given":"Tadashi","family":"Miyamoto","sequence":"additional","affiliation":[]},{"given":"Akinori","family":"Miyashita","sequence":"additional","affiliation":[]},{"given":"Ryozo","family":"Kuwano","sequence":"additional","affiliation":[]},{"given":"Hiroshi","family":"Tanaka","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,5,30]]},"reference":[{"issue":"9770","key":"896_CR1","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","volume":"377","author":"C Ballard","year":"2011","unstructured":"Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E: Alzheimer\u2019s disease. Lancet 2011,377(9770):1019-1031. 10.1016\/S0140-6736(10)61349-9","journal-title":"Lancet"},{"issue":"9503","key":"896_CR2","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","volume":"366","author":"CP Ferri","year":"2005","unstructured":"Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, et al., et al.: Global prevalence of dementia: a Delphi consensus study. Lancet 2005,366(9503):2112-2117.","journal-title":"Lancet"},{"key":"896_CR3","volume-title":"World Alzheimer\u2019s Report","author":"Alzheimer\u2019s Disease Interanational","year":"2010","unstructured":"Alzheimer\u2019s Disease Interanational: World Alzheimer\u2019s Report 2010. http:\/\/www.alz.co.uk\/research\/files\/WorldAlzheimerReport2010ExecutiveSummary.pdf"},{"issue":"1","key":"896_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng1934","volume":"39","author":"L Bertram","year":"2007","unstructured":"Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE: Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 2007,39(1):17-23. 10.1038\/ng1934","journal-title":"Nat Genet"},{"key":"896_CR5","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/msb.2009.47","volume":"5","author":"A Bauer-Mehren","year":"2009","unstructured":"Bauer-Mehren A, Furlong LI, Sanz F: Pathway databases and tools for their exploitation: benefits, current limitations and challenges. Mol Syst Biol 2009, 5: 290.","journal-title":"Mol Syst Biol"},{"key":"896_CR6","doi-asserted-by":"crossref","first-page":"2005.0010","DOI":"10.1038\/msb4100014","volume":"1","author":"K Oda","year":"2005","unstructured":"Oda K, Matsuoka Y, Funahashi A, Kitano H: A comprehensive pathway map of epidermal growth factor receptor signaling. Mol Syst Biol 2005, 1: 2005.0010.","journal-title":"Mol Syst Biol"},{"key":"896_CR7","doi-asserted-by":"crossref","first-page":"2006.0015","DOI":"10.1038\/msb4100057","volume":"2","author":"K Oda","year":"2006","unstructured":"Oda K, Kitano H: A comprehensive map of the toll-like receptor signaling network. Mol Syst Biol 2006, 2: 2006.0015.","journal-title":"Mol Syst Biol"},{"key":"896_CR8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/msb.2008.7","volume":"4","author":"L Calzone","year":"2008","unstructured":"Calzone L, Gelay A, Zinovyev A, Radvanyi F, Barillot E: A comprehensive modular map of molecular interactions in RB\/E2F pathway. Mol Syst Biol 2008, 4: 173.","journal-title":"Mol Syst Biol"},{"key":"896_CR9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/msb.2010.108","volume":"6","author":"E Caron","year":"2010","unstructured":"Caron E, Ghosh S, Matsuoka Y, Ashton-Beaucage D, Therrien M, Lemieux S, Perreault C, Roux PP, Kitano H: A comprehensive map of the mTOR signaling network. Mol Syst Biol 2010, 6: 453.","journal-title":"Mol Syst Biol"},{"key":"896_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/1752-0509-4-137","volume":"4","author":"S Patil","year":"2010","unstructured":"Patil S, Pincas H, Seto J, Nudelman G, Nudelman I, Sealfon SC: Signaling network of dendritic cells in response to pathogens: a community-input supported knowledgebase. BMC Syst Biol 2010, 4: 137. 10.1186\/1752-0509-4-137","journal-title":"BMC Syst Biol"},{"issue":"8","key":"896_CR11","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1109\/JPROC.2008.925458","volume":"96","author":"A Funahashi","year":"2008","unstructured":"Funahashi A, Matsuoka Y, Jouraku A, Morohashi M, Kikuchi N, Kitano H: CellDesigner 3.5: a versatile modeling tool for biochemical networks. Proc IEEE 2008,96(8):1254-1265.","journal-title":"Proc IEEE"},{"issue":"8","key":"896_CR12","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nbt.1558","volume":"27","author":"N Le Nov\u00e8re","year":"2009","unstructured":"Le Nov\u00e8re N, Hucka M, Mi H, Moodie S, Schreiber F, Sorokin A, Demir E, Wegner K, Aladjem MI, Wimalaratne SM, et al., et al.: The Systems Biology Graphical Notation. Nat Biotechnol 2009,27(8):735-741. 10.1038\/nbt.1558","journal-title":"Nat Biotechnol"},{"issue":"4","key":"896_CR13","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1093\/bioinformatics\/btg015","volume":"19","author":"M Hucka","year":"2003","unstructured":"Hucka M, Finney A, Sauro HM, Bolouri H, Doyle JC, Kitano H, Arkin AP, Bornstein BJ, Bray D, Cornish-Bowden A, et al., et al.: The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics 2003,19(4):524-531. 10.1093\/bioinformatics\/btg015","journal-title":"Bioinformatics"},{"key":"896_CR14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1752-0509-1-58","volume":"1","author":"C Laibe","year":"2007","unstructured":"Laibe C, Le Nov\u00e8re N: MIRIAM Resources: tools to generate and resolve robust cross-references in Systems Biology. BMC Syst Biol 2007, 1: 58. 10.1186\/1752-0509-1-58","journal-title":"BMC Syst Biol"},{"issue":"10","key":"896_CR15","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1093\/bioinformatics\/btq143","volume":"26","author":"Y Matsuoka","year":"2010","unstructured":"Matsuoka Y, Ghosh S, Kikuchi N, Kitano H: Payao: A community platform for SBML pathway model curation. Bioinformatics 2010,26(10):1381-1383. 10.1093\/bioinformatics\/btq143","journal-title":"Bioinformatics"},{"issue":"4","key":"896_CR16","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1046\/j.1472-8206.2003.00153.x","volume":"17","author":"H Allain","year":"2003","unstructured":"Allain H, Bentu\u00e9-Ferrer D, Tribut O, Gauthier S, Michel BF, Drieu-La Rochelle C: Alzheimer\u2019s disease: the pharmacological pathway. Fundam Clin Pharmacol 2003,17(4):419-428. 10.1046\/j.1472-8206.2003.00153.x","journal-title":"Fundam Clin Pharmacol"},{"key":"896_CR17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1749-6632.2000.tb06931.x","volume":"920","author":"T Arendt","year":"2000","unstructured":"Arendt T, Holzer M, St\u00f6be A, G\u00e4rtner U, L\u00fcth HJ, Br\u00fcckner MK, Ueberham U: Activated mitogenic signaling induces a process of dedifferentiation in Alzheimer\u2019s disease that eventually results in cell death. Ann N Y Acad Sci 2000, 920: 249-255.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"896_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.arr.2004.02.002","volume":"3","author":"H Atamna","year":"2004","unstructured":"Atamna H: Heme, iron, and the mitochondrial decay of ageing. Ageing Res Rev 2004,3(3):303-318. 10.1016\/j.arr.2004.02.002","journal-title":"Ageing Res Rev"},{"issue":"11","key":"896_CR19","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s007020070021","volume":"107","author":"C Behl","year":"2000","unstructured":"Behl C: Apoptosis and Alzheimer\u2019s disease. J Neural Transm 2000,107(11):1325-1344. 10.1007\/s007020070021","journal-title":"J Neural Transm"},{"issue":"6","key":"896_CR20","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1365-2796.2006.01725.x","volume":"260","author":"I Bj\u00f6rkhem","year":"2006","unstructured":"Bj\u00f6rkhem I: Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J Intern Med 2006,260(6):493-508. 10.1111\/j.1365-2796.2006.01725.x","journal-title":"J Intern Med"},{"issue":"2","key":"896_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.arr.2008.11.003","volume":"8","author":"RA Boonen","year":"2009","unstructured":"Boonen RA, van Tijn P, Zivkovic D: Wnt signaling in Alzheimer\u2019s disease: up or down, that is the question. Ageing Res Rev 2009,8(2):71-82. 10.1016\/j.arr.2008.11.003","journal-title":"Ageing Res Rev"},{"issue":"9","key":"896_CR22","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1111\/j.1582-4934.2011.01318.x","volume":"15","author":"D Bosco","year":"2011","unstructured":"Bosco D, Fava A, Plastino M, Montalcini T, Pujia A: Possible implications of insulin resistance and glucose metabolism in Alzheimer\u2019s disease pathogenesis. J Cell Mol Med 2011,15(9):1807-1821. 10.1111\/j.1582-4934.2011.01318.x","journal-title":"J Cell Mol Med"},{"issue":"13\u201314","key":"896_CR23","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.addr.2008.06.003","volume":"60","author":"RD Brinton","year":"2008","unstructured":"Brinton RD: Estrogen regulation of glucose metabolism and mitochondrial function: therapeutic implications for prevention of Alzheimer\u2019s disease. Adv Drug Deliv Rev 2008,60(13\u201314):1504-1511.","journal-title":"Adv Drug Deliv Rev"},{"issue":"9\u201310","key":"896_CR24","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.clinbiochem.2007.03.016","volume":"40","author":"I Buhaescu","year":"2007","unstructured":"Buhaescu I, Izzedine H: Mevalonate pathway: a review of clinical and therapeutical implications. Clin Biochem 2007,40(9\u201310):575-584.","journal-title":"Clin Biochem"},{"issue":"4","key":"896_CR25","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.phrs.2010.05.002","volume":"62","author":"E Buoso","year":"2010","unstructured":"Buoso E, Lanni C, Schettini G, Govoni S, Racchi M: beta-Amyloid precursor protein metabolism: focus on the functions and degradation of its intracellular domain. Pharmacol Res 2010,62(4):308-317. 10.1016\/j.phrs.2010.05.002","journal-title":"Pharmacol Res"},{"key":"896_CR26","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1749-6632.2002.tb04839.x","volume":"977","author":"M Burns","year":"2002","unstructured":"Burns M, Duff K: Cholesterol in Alzheimer\u2019s disease and tauopathy. Ann N Y Acad Sci 2002, 977: 367-375. 10.1111\/j.1749-6632.2002.tb04839.x","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"896_CR27","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.nbd.2009.10.006","volume":"37","author":"B Cameron","year":"2010","unstructured":"Cameron B, Landreth GE: Inflammation, microglia, and Alzheimer\u2019s disease. Neurobiol Dis 2010,37(3):503-509. 10.1016\/j.nbd.2009.10.006","journal-title":"Neurobiol Dis"},{"issue":"5\u20136","key":"896_CR28","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10540-005-2893-6","volume":"25","author":"A Caricasole","year":"2005","unstructured":"Caricasole A, Bakker A, Copani A, Nicoletti F, Gaviraghi G, Terstappen GC: Two sides of the same coin: Wnt signaling in neurodegeneration and neuro-oncology. Biosci Rep 2005,25(5\u20136):309-327.","journal-title":"Biosci Rep"},{"issue":"5","key":"896_CR29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0165-6147(03)00100-7","volume":"24","author":"A Caricasole","year":"2003","unstructured":"Caricasole A, Copani A, Caruso A, Caraci F, Iacovelli L, Sortino MA, Terstappen GC, Nicoletti F: The Wnt pathway, cell-cycle activation and beta-amyloid: novel therapeutic strategies in Alzheimer\u2019s disease? Trends Pharmacol Sci 2003,24(5):233-238. 10.1016\/S0165-6147(03)00100-7","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"896_CR30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1023\/B:APPT.0000031447.05354.9f","volume":"9","author":"YZ Chen","year":"2004","unstructured":"Chen YZ: APP induces neuronal apoptosis through APP-BP1-mediated downregulation of beta-catenin. Apoptosis 2004,9(4):415-422.","journal-title":"Apoptosis"},{"issue":"1","key":"896_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresrev.2004.11.005","volume":"49","author":"ZZ Chong","year":"2005","unstructured":"Chong ZZ, Li F, Maiese K: Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer\u2019s disease. Brain Res Brain Res Rev 2005,49(1):1-21.","journal-title":"Brain Res Brain Res Rev"},{"issue":"2","key":"896_CR32","first-page":"495","volume":"19","author":"ZZ Chong","year":"2004","unstructured":"Chong ZZ, Maiese K: Targeting WNT, protein kinase B, and mitochondrial membrane integrity to foster cellular survival in the nervous system. Histol Histopathol 2004,19(2):495-504.","journal-title":"Histol Histopathol"},{"issue":"1","key":"896_CR33","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1054\/mehy.2000.1148","volume":"56","author":"RL Chorsky","year":"2001","unstructured":"Chorsky RL, Yaghmai F, Hill WD, Stopa EG: Alzheimer\u2019s disease: a review concerning immune response and microischemia. Med Hypotheses 2001,56(1):124-127. 10.1054\/mehy.2000.1148","journal-title":"Med Hypotheses"},{"issue":"4","key":"896_CR34","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0021-9258(17)34182-0","volume":"254","author":"YM Choy","year":"1979","unstructured":"Choy YM, Lau KM, Lee CY: Purification and characterization of urinary choriogonadotropin from patients with hydatidiform mole. J Biol Chem 1979,254(4):1159-1163.","journal-title":"J Biol Chem"},{"issue":"4","key":"896_CR35","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.bbadis.2006.10.016","volume":"1772","author":"A Copani","year":"2007","unstructured":"Copani A, Caraci F, Hoozemans JJ, Calafiore M, Sortino MA, Nicoletti F: The nature of the cell cycle in neurons: focus on a \u201cnon-canonical\u201d pathway of DNA replication causally related to death. Biochim Biophys Acta 2007,1772(4):409-412. 10.1016\/j.bbadis.2006.10.016","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"896_CR36","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.arr.2011.01.001","volume":"10","author":"SC Correia","year":"2011","unstructured":"Correia SC, Santos RX, Perry G, Zhu X, Moreira PI, Smith MA: Insulin-resistant brain state: the culprit in sporadic Alzheimer\u2019s disease? Ageing Res Rev 2011,10(2):264-273. 10.1016\/j.arr.2011.01.001","journal-title":"Ageing Res Rev"},{"issue":"2","key":"896_CR37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0163-7258(00)00036-X","volume":"86","author":"CM Coughlan","year":"2000","unstructured":"Coughlan CM, Breen KC: Factors influencing the processing and function of the amyloid beta precursor protein\u2013a potential therapeutic target in Alzheimer\u2019s disease? Pharmacol Ther 2000,86(2):111-145. 10.1016\/S0163-7258(00)00036-X","journal-title":"Pharmacol Ther"},{"issue":"3","key":"896_CR38","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/j.1471-4159.2006.03905.x","volume":"98","author":"EJ Coulson","year":"2006","unstructured":"Coulson EJ: Does the p75 neurotrophin receptor mediate Abeta-induced toxicity in Alzheimer\u2019s disease? J Neurochem 2006,98(3):654-660. 10.1111\/j.1471-4159.2006.03905.x","journal-title":"J Neurochem"},{"issue":"4","key":"896_CR39","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.tig.2008.01.004","volume":"24","author":"M Cruts","year":"2008","unstructured":"Cruts M, Van Broeckhoven C: Loss of progranulin function in frontotemporal lobar degeneration. Trends Genet 2008,24(4):186-194. 10.1016\/j.tig.2008.01.004","journal-title":"Trends Genet"},{"issue":"6","key":"896_CR40","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s11064-006-9270-0","volume":"32","author":"AC Cuello","year":"2007","unstructured":"Cuello AC, Bruno MA: The failure in NGF maturation and its increased degradation as the probable cause for the vulnerability of cholinergic neurons in Alzheimer\u2019s disease. Neurochem Res 2007,32(6):1041-1045. 10.1007\/s11064-006-9270-0","journal-title":"Neurochem Res"},{"issue":"8","key":"896_CR41","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.bbamcr.2007.03.010","volume":"1773","author":"A Cuenda","year":"2007","unstructured":"Cuenda A, Rousseau S: p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta 2007,1773(8):1358-1375. 10.1016\/j.bbamcr.2007.03.010","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"896_CR42","first-page":"RA214","volume":"13","author":"UN Das","year":"2007","unstructured":"Das UN: Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation. Med Sci Monit 2007,13(12):RA214-RA221.","journal-title":"Med Sci Monit"},{"issue":"8","key":"896_CR43","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.euroneuro.2006.01.006","volume":"16","author":"SI Deutsch","year":"2006","unstructured":"Deutsch SI, Rosse RB, Deutsch LH: Faulty regulation of tau phosphorylation by the reelin signal transduction pathway is a potential mechanism of pathogenesis and therapeutic target in Alzheimer\u2019s disease. Eur Neuropsychopharmacol 2006,16(8):547-551. 10.1016\/j.euroneuro.2006.01.006","journal-title":"Eur Neuropsychopharmacol"},{"issue":"8","key":"896_CR44","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1007\/s11064-007-9322-0","volume":"32","author":"LF Dmitriev","year":"2007","unstructured":"Dmitriev LF: Shortage of lipid-radical cycles in membranes as a possible prime cause of energetic failure in aging and Alzheimer disease. Neurochem Res 2007,32(8):1278-1291. 10.1007\/s11064-007-9322-0","journal-title":"Neurochem Res"},{"issue":"8","key":"896_CR45","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/S0006-2952(03)00534-3","volume":"66","author":"A Eckert","year":"2003","unstructured":"Eckert A, Keil U, Marques CA, Bonert A, Frey C, Sch\u00fcssel K, M\u00fcller WE: Mitochondrial dysfunction, apoptotic cell death, and Alzheimer\u2019s disease. Biochem Pharmacol 2003,66(8):1627-1634. 10.1016\/S0006-2952(03)00534-3","journal-title":"Biochem Pharmacol"},{"key":"896_CR46","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1196\/annals.1299.113","volume":"1010","author":"A Eckert","year":"2003","unstructured":"Eckert A, Marques CA, Keil U, Sch\u00fcssel K, M\u00fcller WE: Increased apoptotic cell death in sporadic and genetic Alzheimer\u2019s disease. Ann N Y Acad Sci 2003, 1010: 604-609. 10.1196\/annals.1299.113","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"896_CR47","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.bbalip.2010.02.002","volume":"1801","author":"AA Farooqui","year":"2010","unstructured":"Farooqui AA, Ong WY, Farooqui T: Lipid mediators in the nucleus: Their potential contribution to Alzheimer\u2019s disease. Biochim Biophys Acta 2010,1801(8):906-916. 10.1016\/j.bbalip.2010.02.002","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"896_CR48","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00249-007-0244-1","volume":"37","author":"G Filiz","year":"2008","unstructured":"Filiz G, Price KA, Caragounis A, Du T, Crouch PJ, White AR: The role of metals in modulating metalloprotease activity in the AD brain. Eur Biophys J 2008,37(3):315-321. 10.1007\/s00249-007-0244-1","journal-title":"Eur Biophys J"},{"issue":"6","key":"896_CR49","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.biochi.2009.03.004","volume":"91","author":"S Florent-B\u00e9chard","year":"2009","unstructured":"Florent-B\u00e9chard S, Desb\u00e8ne C, Garcia P, Allouche A, Youssef I, Escany\u00e9 MC, Koziel V, Hanse M, Malaplate-Armand C, Stenger C, et al., et al.: The essential role of lipids in Alzheimer\u2019s disease. Biochimie 2009,91(6):804-809. 10.1016\/j.biochi.2009.03.004","journal-title":"Biochimie"},{"issue":"1","key":"896_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0925-4439(00)00028-4","volume":"1502","author":"PE Fraser","year":"2000","unstructured":"Fraser PE, Yang DS, Yu G, L\u00e9vesque L, Nishimura M, Arawaka S, Serpell LC, Rogaeva E, St George-Hyslop P: Presenilin structure, function and role in Alzheimer disease. Biochim Biophys Acta 2000,1502(1):1-15. 10.1016\/S0925-4439(00)00028-4","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20133","key":"896_CR51","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.brainresrev.2004.07.018","volume":"47","author":"RA Fuentealba","year":"2004","unstructured":"Fuentealba RA, Farias G, Scheu J, Bronfman M, Marzolo MP, Inestrosa NC: Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease. Brain Res Brain Res Rev 2004,47(1\u20133):275-289.","journal-title":"Brain Res Brain Res Rev"},{"issue":"5","key":"896_CR52","first-page":"1121","volume":"115","author":"S Gandy","year":"2005","unstructured":"Gandy S: The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. J Clin Invest 2005,115(5):1121-1129.","journal-title":"J Clin Invest"},{"issue":"1","key":"896_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0306-4522(99)00059-7","volume":"91","author":"U G\u00e4rtner","year":"1999","unstructured":"G\u00e4rtner U, Holzer M, Arendt T: Elevated expression of p21ras is an early event in Alzheimer\u2019s disease and precedes neurofibrillary degeneration. Neuroscience 1999,91(1):1-5. 10.1016\/S0306-4522(99)00059-7","journal-title":"Neuroscience"},{"issue":"8","key":"896_CR54","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S0166-2236(03)00163-2","volume":"26","author":"L Gasparini","year":"2003","unstructured":"Gasparini L, Xu H: Potential roles of insulin and IGF-1 in Alzheimer\u2019s disease. Trends Neurosci 2003,26(8):404-406. 10.1016\/S0166-2236(03)00163-2","journal-title":"Trends Neurosci"},{"issue":"3","key":"896_CR55","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.nurt.2008.05.007","volume":"5","author":"AK Ghosh","year":"2008","unstructured":"Ghosh AK, Gemma S, Tang J: beta-Secretase as a therapeutic target for Alzheimer\u2019s disease. Neurotherapeutics 2008,5(3):399-408. 10.1016\/j.nurt.2008.05.007","journal-title":"Neurotherapeutics"},{"issue":"6","key":"896_CR56","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","volume":"140","author":"CK Glass","year":"2010","unstructured":"Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH: Mechanisms underlying inflammation in neurodegeneration. Cell 2010,140(6):918-934. 10.1016\/j.cell.2010.02.016","journal-title":"Cell"},{"issue":"2\u20133","key":"896_CR57","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0960-0760(03)00043-8","volume":"84","author":"S Goodenough","year":"2003","unstructured":"Goodenough S, Sch\u00e4fer M, Behl C: Estrogen-induced cell signalling in a cellular model of Alzheimer\u2019s disease. J Steroid Biochem Mol Biol 2003,84(2\u20133):301-305.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1\u20132","key":"896_CR58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1440-1681.2000.03200.x","volume":"27","author":"G Halliday","year":"2000","unstructured":"Halliday G, Robinson SR, Shepherd C, Kril J: Alzheimer\u2019s disease and inflammation: a review of cellular and therapeutic mechanisms. Clin Exp Pharmacol Physiol 2000,27(1\u20132):1-8.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"13","key":"896_CR59","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1007\/s00018-005-5599-9","volume":"63","author":"T Hamaguchi","year":"2006","unstructured":"Hamaguchi T, Ono K, Yamada M: Anti-amyloidogenic therapies: strategies for prevention and treatment of Alzheimer\u2019s disease. Cell Mol Life Sci 2006,63(13):1538-1552. 10.1007\/s00018-005-5599-9","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"896_CR60","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/S0006-2952(03)00533-1","volume":"66","author":"M Hamdane","year":"2003","unstructured":"Hamdane M, Delobel P, Sambo AV, Smet C, B\u00e9gard S, Violleau A, Landrieu I, Delacourte A, Lippens G, Flament S, et al., et al.: Neurofibrillary degeneration of the Alzheimer-type: an alternate pathway to neuronal apoptosis? Biochem Pharmacol 2003,66(8):1619-1625. 10.1016\/S0006-2952(03)00533-1","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"896_CR61","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, et al., et al.: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat Genet 2009,41(10):1088-1093. 10.1038\/ng.440","journal-title":"Nat Genet"},{"issue":"2","key":"896_CR62","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1385\/JMN:17:2:171","volume":"17","author":"D Hartmann","year":"2001","unstructured":"Hartmann D, Tournoy J, Saftig P, Annaert W, De Strooper B: Implication of APP secretases in notch signaling. J Mol Neurosci 2001,17(2):171-181. 10.1385\/JMN:17:2:171","journal-title":"J Mol Neurosci"},{"issue":"6","key":"896_CR63","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s004060050102","volume":"249","author":"T Hartmann","year":"1999","unstructured":"Hartmann T: Intracellular biology of Alzheimer\u2019s disease amyloid beta peptide. Eur Arch Psychiatry Clin Neurosci 1999,249(6):291-298. 10.1007\/s004060050102","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"11","key":"896_CR64","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.tins.2007.08.005","volume":"30","author":"AN Hegde","year":"2007","unstructured":"Hegde AN, Upadhya SC: The ubiquitin-proteasome pathway in health and disease of the nervous system. Trends Neurosci 2007,30(11):587-595. 10.1016\/j.tins.2007.08.005","journal-title":"Trends Neurosci"},{"issue":"5","key":"896_CR65","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/j.1471-4159.2010.07032.x","volume":"116","author":"D Hicks","year":"2011","unstructured":"Hicks D, John D, Makova NZ, Henderson Z, Nalivaeva NN, Turner AJ: Membrane targeting, shedding and protein interactions of brain acetylcholinesterase. J Neurochem 2011,116(5):742-746. 10.1111\/j.1471-4159.2010.07032.x","journal-title":"J Neurochem"},{"issue":"9","key":"896_CR66","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.neurobiolaging.2008.08.023","volume":"31","author":"C H\u00f6lscher","year":"2010","unstructured":"H\u00f6lscher C, Li L: New roles for insulin-like hormones in neuronal signalling and protection: new hopes for novel treatments of Alzheimer\u2019s disease? Neurobiol Aging 2010,31(9):1495-1502. 10.1016\/j.neurobiolaging.2008.08.023","journal-title":"Neurobiol Aging"},{"issue":"Pt 2","key":"896_CR67","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1042\/BST0330335","volume":"33","author":"NM Hooper","year":"2005","unstructured":"Hooper NM: Roles of proteolysis and lipid rafts in the processing of the amyloid precursor protein and prion protein. Biochem Soc Trans 2005,33(Pt 2):335-338.","journal-title":"Biochem Soc Trans"},{"issue":"4\u20135","key":"896_CR68","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1080\/15216540701242490","volume":"59","author":"NC Inestrosa","year":"2007","unstructured":"Inestrosa NC, Varela-Nallar L, Grabowski CP, Colombres M: Synaptotoxicity in Alzheimer\u2019s disease: the Wnt signaling pathway as a molecular target. IUBMB Life 2007,59(4\u20135):316-321.","journal-title":"IUBMB Life"},{"issue":"6 Pt 1","key":"896_CR69","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.diabet.2010.09.001","volume":"36","author":"T Issad","year":"2010","unstructured":"Issad T, Masson E, Pagesy P: O-GlcNAc modification, insulin signaling and diabetic complications. Diabetes Metab 2010,36(6 Pt 1):423-435.","journal-title":"Diabetes Metab"},{"issue":"1","key":"896_CR70","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1254\/fpj.122.5","volume":"122","author":"N Iwata","year":"2003","unstructured":"Iwata N, Saido TC: Amyloid-beta peptide metabolism and Alzheimer\u2019s disease. Nihon Yakurigaku Zasshi 2003,122(1):5-14. 10.1254\/fpj.122.5","journal-title":"Nihon Yakurigaku Zasshi"},{"issue":"2","key":"896_CR71","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0014-4886(03)00268-1","volume":"183","author":"GV Johnson","year":"2003","unstructured":"Johnson GV, Bailey CD: The p38 MAP kinase signaling pathway in Alzheimer\u2019s disease. Exp Neurol 2003,183(2):263-268. 10.1016\/S0014-4886(03)00268-1","journal-title":"Exp Neurol"},{"issue":"3","key":"896_CR72","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00726-004-0072-x","volume":"26","author":"P Kamoun","year":"2004","unstructured":"Kamoun P: Endogenous production of hydrogen sulfide in mammals. Amino Acids 2004,26(3):243-254.","journal-title":"Amino Acids"},{"issue":"1\u20132","key":"896_CR73","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jchemneu.2003.12.004","volume":"28","author":"T Katayama","year":"2004","unstructured":"Katayama T, Imaizumi K, Manabe T, Hitomi J, Kudo T, Tohyama M: Induction of neuronal death by ER stress in Alzheimer\u2019s disease. J Chem Neuroanat 2004,28(1\u20132):67-78.","journal-title":"J Chem Neuroanat"},{"issue":"6","key":"896_CR74","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.cell.2009.05.042","volume":"137","author":"D Kim","year":"2009","unstructured":"Kim D, Tsai LH: Bridging physiology and pathology in AD. Cell 2009,137(6):997-1000. 10.1016\/j.cell.2009.05.042","journal-title":"Cell"},{"issue":"1","key":"896_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellsig.2007.07.003","volume":"20","author":"J Klysik","year":"2008","unstructured":"Klysik J, Theroux SJ, Sedivy JM, Moffit JS, Boekelheide K: Signaling crossroads: the function of Raf kinase inhibitory protein in cancer, the central nervous system and reproduction. Cell Signal 2008,20(1):1-9. 10.1016\/j.cellsig.2007.07.003","journal-title":"Cell Signal"},{"issue":"9","key":"896_CR76","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/S0891-5849(01)00688-8","volume":"31","author":"A Kontush","year":"2001","unstructured":"Kontush A: Amyloid-beta: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer\u2019s disease. Free Radic Biol Med 2001,31(9):1120-1131. 10.1016\/S0891-5849(01)00688-8","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"896_CR77","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0896-6273(02)00585-8","volume":"33","author":"R Kopan","year":"2002","unstructured":"Kopan R, Goate A: Aph-2\/Nicastrin: an essential component of gamma-secretase and regulator of Notch signaling and Presenilin localization. Neuron 2002,33(3):321-324. 10.1016\/S0896-6273(02)00585-8","journal-title":"Neuron"},{"issue":"3","key":"896_CR78","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1046\/j.1365-2990.2001.00335.x","volume":"27","author":"R Layfield","year":"2001","unstructured":"Layfield R, Alban A, Mayer RJ, Lowe J: The ubiquitin protein catabolic disorders. Neuropathol Appl Neurobiol 2001,27(3):171-179. 10.1046\/j.1365-2990.2001.00335.x","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"8","key":"896_CR79","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00702-010-0433-4","volume":"117","author":"CY Lee","year":"2010","unstructured":"Lee CY, Landreth GE: The role of microglia in amyloid clearance from the AD brain. J Neural Transm 2010,117(8):949-960. 10.1007\/s00702-010-0433-4","journal-title":"J Neural Transm"},{"issue":"2","key":"896_CR80","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.bbagen.2009.08.008","volume":"1800","author":"T Lefebvre","year":"2010","unstructured":"Lefebvre T, Dehennaut V, Guinez C, Olivier S, Drougat L, Mir AM, Mortuaire M, Vercoutter-Edouart AS, Michalski JC: Dysregulation of the nutrient\/stress sensor O-GlcNAcylation is involved in the etiology of cardiovascular disorders, type-2 diabetes and Alzheimer\u2019s disease. Biochim Biophys Acta 2010,1800(2):67-79. 10.1016\/j.bbagen.2009.08.008","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"896_CR81","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.str.2009.01.007","volume":"17","author":"H Li","year":"2009","unstructured":"Li H, Wolfe MS, Selkoe DJ: Toward structural elucidation of the gamma-secretase complex. Structure 2009,17(3):326-334. 10.1016\/j.str.2009.01.007","journal-title":"Structure"},{"issue":"1","key":"896_CR82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-2275(20)33334-4","volume":"40","author":"RW Mahley","year":"1999","unstructured":"Mahley RW, Ji ZS: Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J Lipid Res 1999,40(1):1-16.","journal-title":"J Lipid Res"},{"issue":"12","key":"896_CR83","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00018-004-4012-4","volume":"61","author":"G Mari\u00f1o","year":"2004","unstructured":"Mari\u00f1o G, L\u00f3pez-Ot\u00edn C: Autophagy: molecular mechanisms, physiological functions and relevance in human pathology. Cell Mol Life Sci 2004,61(12):1439-1454.","journal-title":"Cell Mol Life Sci"},{"issue":"Pt 11","key":"896_CR84","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1093\/brain\/awl251","volume":"129","author":"CL Masters","year":"2006","unstructured":"Masters CL, Beyreuther K: Alzheimer\u2019s centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway. Brain 2006,129(Pt 11):2823-2839.","journal-title":"Brain"},{"issue":"4","key":"896_CR85","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1152\/physrev.1997.77.4.1081","volume":"77","author":"MP Mattson","year":"1997","unstructured":"Mattson MP: Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev 1997,77(4):1081-1132.","journal-title":"Physiol Rev"},{"issue":"8","key":"896_CR86","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/bies.1103","volume":"23","author":"MP Mattson","year":"2001","unstructured":"Mattson MP, Chan SL, Camandola S: Presenilin mutations and calcium signaling defects in the nervous and immune systems. Bioessays 2001,23(8):733-744. 10.1002\/bies.1103","journal-title":"Bioessays"},{"key":"896_CR87","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1749-6632.1996.tb34421.x","volume":"777","author":"PL McGeer","year":"1996","unstructured":"McGeer PL, McGeer EG: Anti-inflammatory drugs in the fight against Alzheimer\u2019s disease. Ann N Y Acad Sci 1996, 777: 213-220. 10.1111\/j.1749-6632.1996.tb34421.x","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"896_CR88","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/jnr.21532","volume":"86","author":"DM McLoughlin","year":"2008","unstructured":"McLoughlin DM, Miller CC: The FE65 proteins and Alzheimer\u2019s disease. J Neurosci Res 2008,86(4):744-754. 10.1002\/jnr.21532","journal-title":"J Neurosci Res"},{"issue":"3","key":"896_CR89","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00018-005-5298-6","volume":"63","author":"SJ McTaggart","year":"2006","unstructured":"McTaggart SJ: Isoprenylated proteins. Cell Mol Life Sci 2006,63(3):255-267. 10.1007\/s00018-005-5298-6","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"896_CR90","doi-asserted-by":"crossref","first-page":"1158S","DOI":"10.1093\/ajcn\/76.5.1158S","volume":"76","author":"D Mischoulon","year":"2002","unstructured":"Mischoulon D, Fava M: Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence. Am J Clin Nutr 2002,76(5):1158S-1161S.","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"896_CR91","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1023\/A:1009697908332","volume":"5","author":"KH Moley","year":"2000","unstructured":"Moley KH, Mueckler MM: Glucose transport and apoptosis. Apoptosis 2000,5(2):99-105. 10.1023\/A:1009697908332","journal-title":"Apoptosis"},{"issue":"6","key":"896_CR92","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.pneurobio.2004.10.004","volume":"74","author":"C Morgan","year":"2004","unstructured":"Morgan C, Colombres M, Nu\u00f1ez MT, Inestrosa NC: Structure and function of amyloid in Alzheimer\u2019s disease. Prog Neurobiol 2004,74(6):323-349. 10.1016\/j.pneurobio.2004.10.004","journal-title":"Prog Neurobiol"},{"issue":"3","key":"896_CR93","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1254\/fpj.124.135","volume":"124","author":"Y Nagai","year":"2004","unstructured":"Nagai Y, Ogasawara A, Heese K: Possible mechanisms of A beta(1\u201340)- or A beta(1\u201342)-induced cell death and their rescue factors. Nihon Yakurigaku Zasshi 2004,124(3):135-143. 10.1254\/fpj.124.135","journal-title":"Nihon Yakurigaku Zasshi"},{"issue":"Pt 5","key":"896_CR94","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1042\/BST0331033","volume":"33","author":"TJ Nelson","year":"2005","unstructured":"Nelson TJ, Alkon DL: Insulin and cholesterol pathways in neuronal function, memory and neurodegeneration. Biochem Soc Trans 2005,33(Pt 5):1033-1036.","journal-title":"Biochem Soc Trans"},{"key":"896_CR95","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1749-6632.2000.tb05570.x","volume":"924","author":"RA Nixon","year":"2000","unstructured":"Nixon RA: A \u201cprotease activation cascade\u201d in the pathogenesis of Alzheimer\u2019s disease. Ann N Y Acad Sci 2000, 924: 117-131.","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"896_CR96","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.phrs.2007.04.013","volume":"55","author":"A Pascale","year":"2007","unstructured":"Pascale A, Amadio M, Govoni S, Battaini F: The aging brain, a key target for the future: the protein kinase C involvement. Pharmacol Res 2007,55(6):560-569. 10.1016\/j.phrs.2007.04.013","journal-title":"Pharmacol Res"},{"key":"896_CR97","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1749-6632.2000.tb05564.x","volume":"924","author":"J Poirier","year":"2000","unstructured":"Poirier J: Apolipoprotein E and Alzheimer\u2019s disease. A role in amyloid catabolism. Ann N Y Acad Sci 2000, 924: 81-90.","journal-title":"A role in amyloid catabolism. Ann N Y Acad Sci"},{"issue":"3","key":"896_CR98","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.neurobiolaging.2004.09.003","volume":"26","author":"J Poirier","year":"2005","unstructured":"Poirier J: Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer\u2019s disease. Neurobiol Aging 2005,26(3):355-361. 10.1016\/j.neurobiolaging.2004.09.003","journal-title":"Neurobiol Aging"},{"issue":"6","key":"896_CR99","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.neurobiolaging.2007.01.010","volume":"29","author":"L Puglielli","year":"2008","unstructured":"Puglielli L: Aging of the brain, neurotrophin signaling, and Alzheimer\u2019s disease: is IGF1-R the common culprit? Neurobiol Aging 2008,29(6):795-811. 10.1016\/j.neurobiolaging.2007.01.010","journal-title":"Neurobiol Aging"},{"issue":"3","key":"896_CR100","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1582-4934.2007.00054.x","volume":"11","author":"PC Reid","year":"2007","unstructured":"Reid PC, Urano Y, Kodama T, Hamakubo T: Alzheimer\u2019s disease: cholesterol, membrane rafts, isoprenoids and statins. J Cell Mol Med 2007,11(3):383-392. 10.1111\/j.1582-4934.2007.00054.x","journal-title":"J Cell Mol Med"},{"issue":"Pt 6","key":"896_CR101","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1042\/BST0361282","volume":"36","author":"JT Rogers","year":"2008","unstructured":"Rogers JT, Bush AI, Cho HH, Smith DH, Thomson AM, Friedlich AL, Lahiri DK, Leedman PJ, Huang X, Cahill CM: Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer\u2019s disease. Biochem Soc Trans 2008,36(Pt 6):1282-1287.","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"896_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arcmed.2007.10.001","volume":"39","author":"LE Rojo","year":"2008","unstructured":"Rojo LE, Fern\u00e1ndez JA, Maccioni AA, Jimenez JM, Maccioni RB: Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer\u2019s disease. Arch Med Res 2008,39(1):1-16. 10.1016\/j.arcmed.2007.10.001","journal-title":"Arch Med Res"},{"issue":"3","key":"896_CR103","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.mrrev.2008.06.001","volume":"659","author":"M Rosner","year":"2008","unstructured":"Rosner M, Hanneder M, Siegel N, Valli A, Fuchs C, Hengstschl\u00e4ger M: The mTOR pathway and its role in human genetic diseases. Mutat Res 2008,659(3):284-292. 10.1016\/j.mrrev.2008.06.001","journal-title":"Mutat Res"},{"issue":"7","key":"896_CR104","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.ijdevneu.2004.07.004","volume":"22","author":"S Rossner","year":"2004","unstructured":"Rossner S: New players in old amyloid precursor protein-processing pathways. Int J Dev Neurosci 2004,22(7):467-474. 10.1016\/j.ijdevneu.2004.07.004","journal-title":"Int J Dev Neurosci"},{"issue":"5","key":"896_CR105","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0301-0082(98)00044-6","volume":"56","author":"S Rossner","year":"1998","unstructured":"Rossner S, Ueberham U, Schliebs R, Perez-Polo JR, Bigl V: The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling. Prog Neurobiol 1998,56(5):541-569. 10.1016\/S0301-0082(98)00044-6","journal-title":"Prog Neurobiol"},{"key":"896_CR106","doi-asserted-by":"crossref","first-page":"603052","DOI":"10.4061\/2011\/603052","volume":"2011","author":"JV Rushworth","year":"2010","unstructured":"Rushworth JV, Hooper NM: Lipid Rafts: Linking Alzheimer\u2019s Amyloid-\u03b2 Production, Aggregation, and Toxicity at Neuronal Membranes. Int J Alzheimers Dis 2010, 2011: 603052.","journal-title":"Int J Alzheimers Dis"},{"issue":"3","key":"896_CR107","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.pneurobio.2009.01.001","volume":"87","author":"A Salminen","year":"2009","unstructured":"Salminen A, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T: Inflammation in Alzheimer\u2019s disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors. Prog Neurobiol 2009,87(3):181-194. 10.1016\/j.pneurobio.2009.01.001","journal-title":"Prog Neurobiol"},{"issue":"2","key":"896_CR108","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.bbapap.2004.09.009","volume":"1703","author":"C Sch\u00f6neich","year":"2005","unstructured":"Sch\u00f6neich C: Methionine oxidation by reactive oxygen species: reaction mechanisms and relevance to Alzheimer\u2019s disease. Biochim Biophys Acta 2005,1703(2):111-119. 10.1016\/j.bbapap.2004.09.009","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"896_CR109","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S0959-4388(99)00054-9","volume":"10","author":"DJ Selkoe","year":"2000","unstructured":"Selkoe DJ: Notch and presenilins in vertebrates and invertebrates: implications for neuronal development and degeneration. Curr Opin Neurobiol 2000,10(1):50-57. 10.1016\/S0959-4388(99)00054-9","journal-title":"Curr Opin Neurobiol"},{"key":"896_CR110","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1146\/annurev.neuro.26.041002.131334","volume":"26","author":"D Selkoe","year":"2003","unstructured":"Selkoe D, Kopan R: Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration. Annu Rev Neurosci 2003, 26: 565-597. 10.1146\/annurev.neuro.26.041002.131334","journal-title":"Annu Rev Neurosci"},{"issue":"20","key":"896_CR111","doi-asserted-by":"publisher","first-page":"11049","DOI":"10.1073\/pnas.96.20.11049","volume":"96","author":"S Sinha","year":"1999","unstructured":"Sinha S, Lieberburg I: Cellular mechanisms of beta-amyloid production and secretion. Proc Natl Acad Sci U S A 1999,96(20):11049-11053. 10.1073\/pnas.96.20.11049","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"896_CR112","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1001\/archneurol.2007.64","volume":"65","author":"SA Small","year":"2008","unstructured":"Small SA: Retromer sorting: a pathogenic pathway in late-onset Alzheimer disease. Arch Neurol 2008,65(3):323-328. 10.1001\/archneurol.2007.64","journal-title":"Arch Neurol"},{"issue":"4","key":"896_CR113","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.neuron.2008.11.007","volume":"60","author":"SA Small","year":"2008","unstructured":"Small SA, Duff K: Linking Abeta and tau in late-onset Alzheimer\u2019s disease: a dual pathway hypothesis. Neuron 2008,60(4):534-542. 10.1016\/j.neuron.2008.11.007","journal-title":"Neuron"},{"issue":"11","key":"896_CR114","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.addr.2003.07.007","volume":"55","author":"B Soreghan","year":"2003","unstructured":"Soreghan B, Thomas SN, Yang AJ: Aberrant sphingomyelin\/ceramide metabolic-induced neuronal endosomal\/lysosomal dysfunction: potential pathological consequences in age-related neurodegeneration. Adv Drug Deliv Rev 2003,55(11):1515-1524. 10.1016\/j.addr.2003.07.007","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"896_CR115","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s12035-011-8174-4","volume":"43","author":"DT Stark","year":"2011","unstructured":"Stark DT, Bazan NG: Neuroprotectin D1 induces neuronal survival and downregulation of amyloidogenic processing in Alzheimer\u2019s disease cellular models. Mol Neurobiol 2011,43(2):131-138. 10.1007\/s12035-011-8174-4","journal-title":"Mol Neurobiol"},{"issue":"12","key":"896_CR116","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1001\/archneur.64.12.1706","volume":"64","author":"M Tafti","year":"2007","unstructured":"Tafti M, Ghyselinck NB: Functional implication of the vitamin A signaling pathway in the brain. Arch Neurol 2007,64(12):1706-1711. 10.1001\/archneur.64.12.1706","journal-title":"Arch Neurol"},{"issue":"2","key":"896_CR117","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1254\/jphs.08R29FM","volume":"109","author":"A Takashima","year":"2009","unstructured":"Takashima A: Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: role of GSK-3beta in adult brain. J Pharmacol Sci 2009,109(2):174-178. 10.1254\/jphs.08R29FM","journal-title":"J Pharmacol Sci"},{"issue":"8","key":"896_CR118","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1248\/yakushi.126.607","volume":"126","author":"Y Takatori","year":"2006","unstructured":"Takatori Y: Mechanisms of neuroprotective effects of therapeutic acetylcholinesterase inhibitors used in treatment of Alzheimer\u2019s disease. Yakugaku Zasshi 2006,126(8):607-616. 10.1248\/yakushi.126.607","journal-title":"Yakugaku Zasshi"},{"issue":"3","key":"896_CR119","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.pneurobio.2008.08.001","volume":"86","author":"EM Toledo","year":"2008","unstructured":"Toledo EM, Colombres M, Inestrosa NC: Wnt signaling in neuroprotection and stem cell differentiation. Prog Neurobiol 2008,86(3):281-296. 10.1016\/j.pneurobio.2008.08.001","journal-title":"Prog Neurobiol"},{"key":"896_CR120","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1749-6632.2002.tb04799.x","volume":"977","author":"KP Townsend","year":"2002","unstructured":"Townsend KP, Obregon D, Quadros A, Patel N, Volmar C, Paris D, Mullan M: Proinflammatory and vasoactive effects of Abeta in the cerebrovasculature. Ann N Y Acad Sci 2002, 977: 65-76. 10.1111\/j.1749-6632.2002.tb04799.x","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"896_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0301-0082(03)00089-3","volume":"70","author":"PR Turner","year":"2003","unstructured":"Turner PR, O\u2019Connor K, Tate WP, Abraham WC: Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog Neurobiol 2003,70(1):1-32. 10.1016\/S0301-0082(03)00089-3","journal-title":"Prog Neurobiol"},{"issue":"2","key":"896_CR122","first-page":"150","volume":"59","author":"S Uthayathas","year":"2007","unstructured":"Uthayathas S, Karuppagounder SS, Thrash BM, Parameshwaran K, Suppiramaniam V, Dhanasekaran M: Versatile effects of sildenafil: recent pharmacological applications. Pharmacol Rep 2007,59(2):150-163.","journal-title":"Pharmacol Rep"},{"key":"896_CR123","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1749-6632.2000.tb06354.x","volume":"903","author":"WE Van Nostrand","year":"2000","unstructured":"Van Nostrand WE, Melchor J, Wagner M, Davis J: Cerebrovascular smooth muscle cell surface fibrillar A beta. Alteration of the proteolytic environment in the cerebral vessel wall. Ann N Y Acad Sci 2000, 903: 89-96. 10.1111\/j.1749-6632.2000.tb06354.x","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"896_CR124","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.brainresrev.2007.12.001","volume":"58","author":"S Vasto","year":"2008","unstructured":"Vasto S, Candore G, List\u00ec F, Balistreri CR, Colonna-Romano G, Malavolta M, Lio D, Nuzzo D, Mocchegiani E, Di Bona D, et al., et al.: Inflammation, genes and zinc in Alzheimer\u2019s disease. Brain Res Rev 2008,58(1):96-105. 10.1016\/j.brainresrev.2007.12.001","journal-title":"Brain Res Rev"},{"issue":"8","key":"896_CR125","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.bbalip.2010.03.007","volume":"1801","author":"KS Vetrivel","year":"2010","unstructured":"Vetrivel KS, Thinakaran G: Membrane rafts in Alzheimer\u2019s disease beta-amyloid production. Biochim Biophys Acta 2010,1801(8):860-867. 10.1016\/j.bbalip.2010.03.007","journal-title":"Biochim Biophys Acta"},{"key":"896_CR126","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev.pharmtox.44.101802.121840","volume":"44","author":"LH Wang","year":"2004","unstructured":"Wang LH, Besirli CG, Johnson EM: Mixed-lineage kinases: a target for the prevention of neurodegeneration. Annu Rev Pharmacol Toxicol 2004, 44: 451-474. 10.1146\/annurev.pharmtox.44.101802.121840","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"10","key":"896_CR127","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.tips.2007.09.004","volume":"28","author":"S Weggen","year":"2007","unstructured":"Weggen S, Rogers M, Eriksen J: NSAIDs: small molecules for prevention of Alzheimer\u2019s disease or precursors for future drug development? Trends Pharmacol Sci 2007,28(10):536-543. 10.1016\/j.tips.2007.09.004","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"896_CR128","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1097\/BOR.0b013e32833de1a7","volume":"22","author":"J Wei","year":"2010","unstructured":"Wei J, Bhattacharyya S, Varga J: Peroxisome proliferator-activated receptor \u03b3: innate protection from excessive fibrogenesis and potential therapeutic target in systemic sclerosis. Curr Opin Rheumatol 2010,22(6):671-676. 10.1097\/BOR.0b013e32833de1a7","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"896_CR129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1399-0004.2000.570101.x","volume":"57","author":"CL Wellington","year":"2000","unstructured":"Wellington CL, Hayden MR: Caspases and neurodegeneration: on the cutting edge of new therapeutic approaches. Clin Genet 2000,57(1):1-10.","journal-title":"Clin Genet"},{"issue":"100","key":"896_CR130","doi-asserted-by":"crossref","first-page":"re12","DOI":"10.1126\/stke.2001.100.re12","volume":"2001","author":"JR Woodgett","year":"2001","unstructured":"Woodgett JR: Judging a protein by more than its name: GSK-3. Sci STKE 2001,2001(100):re12.","journal-title":"Sci STKE"},{"issue":"3","key":"896_CR131","first-page":"123","volume":"61","author":"HY Wu","year":"2007","unstructured":"Wu HY, Tomizawa K, Matsui H: Calpain-calcineurin signaling in the pathogenesis of calcium-dependent disorder. Acta Med Okayama 2007,61(3):123-137.","journal-title":"Acta Med Okayama"},{"issue":"1","key":"896_CR132","doi-asserted-by":"crossref","first-page":"a006346","DOI":"10.1101\/cshperspect.a006346","volume":"2","author":"T Wyss-Coray","year":"2012","unstructured":"Wyss-Coray T, Rogers J: Inflammation in Alzheimer Disease\u2212\u2212A Brief Review of the Basic Science and Clinical Literature. Cold Spring Harbor Perspect Med 2012,2(1):a006346.","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"2","key":"896_CR133","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1172\/JCI11914","volume":"107","author":"Y Yamamoto","year":"2001","unstructured":"Yamamoto Y, Gaynor RB: Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 2001,107(2):135-142. 10.1172\/JCI11914","journal-title":"J Clin Invest"},{"issue":"1\u20132","key":"896_CR134","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ymgme.2007.06.001","volume":"92","author":"SY Yang","year":"2007","unstructured":"Yang SY, He XY, Miller D: HSD17B10: a gene involved in cognitive function through metabolism of isoleucine and neuroactive steroids. Mol Genet Metab 2007,92(1\u20132):36-42.","journal-title":"Mol Genet Metab"},{"key":"896_CR135","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1196\/annals.1377.013","volume":"1086","author":"T Yoshimura","year":"2006","unstructured":"Yoshimura T, Arimura N, Kaibuchi K: Molecular mechanisms of axon specification and neuronal disorders. Ann N Y Acad Sci 2006, 1086: 116-125. 10.1196\/annals.1377.013","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"896_CR136","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.bbadis.2008.10.014","volume":"1792","author":"WQ Zhao","year":"2009","unstructured":"Zhao WQ, Townsend M: Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer\u2019s disease. Biochim Biophys Acta 2009,1792(5):482-496. 10.1016\/j.bbadis.2008.10.014","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"896_CR137","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.tips.2007.05.001","volume":"28","author":"F Zipp","year":"2007","unstructured":"Zipp F, Waiczies S, Aktas O, Neuhaus O, Hemmer B, Schraven B, Nitsch R, Hartung HP: Impact of HMG-CoA reductase inhibition on brain pathology. Trends Pharmacol Sci 2007,28(7):342-349. 10.1016\/j.tips.2007.05.001","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"896_CR138","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.nurt.2008.05.011","volume":"5","author":"BV Zlokovic","year":"2008","unstructured":"Zlokovic BV: New therapeutic targets in the neurovascular pathway in Alzheimer\u2019s disease. Neurotherapeutics 2008,5(3):409-414. 10.1016\/j.nurt.2008.05.011","journal-title":"Neurotherapeutics"},{"issue":"3","key":"896_CR139","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/bioinformatics\/btq675","volume":"27","author":"ME Smoot","year":"2011","unstructured":"Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T: Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 2011,27(3):431-432. 10.1093\/bioinformatics\/btq675","journal-title":"Bioinformatics"}],"container-title":["BMC Systems Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-0509-6-52.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T13:36:21Z","timestamp":1743946581000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsystbiol.biomedcentral.com\/articles\/10.1186\/1752-0509-6-52"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,30]]},"references-count":139,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["896"],"URL":"https:\/\/doi.org\/10.1186\/1752-0509-6-52","relation":{},"ISSN":["1752-0509"],"issn-type":[{"value":"1752-0509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,30]]},"assertion":[{"value":"14 February 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"52"}}